The type 1 transmembrane glycoprotein B7‐H3 interacts with the glycolytic enzyme ENO1 to promote malignancy and glycolysis in HeLa cells.

MLA

Zuo, Jiahui, et al. “The Type 1 Transmembrane Glycoprotein B7‐H3 Interacts with the Glycolytic Enzyme ENO1 to Promote Malignancy and Glycolysis in HeLa Cells.” FEBS Letters, vol. 592, no. 14, July 2018, pp. 2476–88. EBSCOhost, https://doi.org/10.1002/1873-3468.13164.

APA

Zuo, J., Wang, B., Long, M., Gao, Z., Zhang, Z., Wang, H., Wang, X., Li, R., Dong, K., & Zhang, H. (2018). The type 1 transmembrane glycoprotein B7‐H3 interacts with the glycolytic enzyme ENO1 to promote malignancy and glycolysis in HeLa cells. FEBS Letters, 592(14), 2476–2488. https://doi.org/10.1002/1873-3468.13164

Chicago

Zuo, Jiahui, Bowen Wang, Min Long, Zhaowei Gao, Zhe Zhang, Huiping Wang, Xi Wang, Ruicheng Li, Ke Dong, and Huizhong Zhang. 2018. “The Type 1 Transmembrane Glycoprotein B7‐H3 Interacts with the Glycolytic Enzyme ENO1 to Promote Malignancy and Glycolysis in HeLa Cells.” FEBS Letters 592 (14): 2476–88. doi:10.1002/1873-3468.13164.